financetom
Business
financetom
/
Business
/
Fs Bancorp Insider Sold Shares Worth $283,798, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fs Bancorp Insider Sold Shares Worth $283,798, According to a Recent SEC Filing
Aug 22, 2025 11:54 AM

02:22 PM EDT, 08/22/2025 (MT Newswires) -- Joseph C. Adams, Director, CEO, on August 21, 2025, sold 7,076 shares in Fs Bancorp ( FSBW ) for $283,798. Following the Form 4 filing with the SEC, Adams has control over a total of 131,864 common shares of the company, with 114,046 shares held directly and 17,818 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1530249/000093905725000238/xslF345X05/primary_doc.xml

Price: 42.53, Change: +2.63, Percent Change: +6.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Journey Medical Gets FDA Approval for Rosacea Treatment
Journey Medical Gets FDA Approval for Rosacea Treatment
Nov 4, 2024
11:12 AM EST, 11/04/2024 (MT Newswires) -- Journey Medical ( DERM ) said Monday the US Food and Drug Administration approved Emrosi for the treatment of inflammatory lesions of rosacea, an inflammatory skin condition, in adults. The company said it is completing the manufacturing of Emrosi for the US market, with initial supply expected to be available late in Q1...
Southside Bancshares to Switch Listing to NYSE from Nasdaq
Southside Bancshares to Switch Listing to NYSE from Nasdaq
Nov 4, 2024
11:14 AM EST, 11/04/2024 (MT Newswires) -- Southside Bancshares ( SBSI ) said Monday it will transfer its listing to the New York Stock Exchange from Nasdaq. The company expects to begin trading on the NYSE on Nov. 15 under the same ticker symbol. Trading of Southside shares on Nasdaq will continue until the close of the market on Nov....
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
Nov 4, 2024
11:12 AM EST, 11/04/2024 (MT Newswires) -- Alvotech ( ALVO ) and Advanz Pharma said Monday that the European Medicines Agency accepted the marketing authorization application for AVT05 to treat several chronic inflammatory diseases. AVT05 is a biosimilar of Simponi and Simponi Aria, or golimumab, which are marketed by Johnson & Johnson's ( JNJ ) Janssen Biotech unit. The approvals...
Update: Nasdaq, Cboe Challenge New SEC Rules Intended to Boost Market Transparency
Update: Nasdaq, Cboe Challenge New SEC Rules Intended to Boost Market Transparency
Nov 4, 2024
11:16 AM EST, 11/04/2024 (MT Newswires) -- (Updates with statements from Nasdaq and Cboe Global Markets ( CBOE ) in third, fourth and fifth paragraphs.) Nasdaq (NDAQ) and Cboe Global Markets ( CBOE ) are challenging recent changes in US stock market rules intended to help investors better understand the costs they pay to trade stocks and other securities. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved